Your browser doesn't support javascript.
loading
Effects of Antibody Response after Booster Vaccination on SARS-CoV-2 Breakthrough Infections and Disease Outcomes in Advanced Cancer Patients: A Prospective Analysis of the Vax-on-Third Study.
Nelli, Fabrizio; Fabbri, Agnese; Virtuoso, Antonella; Giannarelli, Diana; Giron Berrios, Julio Rodrigo; Marrucci, Eleonora; Fiore, Cristina; Schirripa, Marta; Signorelli, Carlo; Chilelli, Mario Giovanni; Primi, Francesca; Pessina, Gloria; Natoni, Federica; Silvestri, Maria Assunta; Ruggeri, Enzo Maria.
Afiliação
  • Nelli F; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, 01100 Viterbo, Italy.
  • Fabbri A; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, 01100 Viterbo, Italy.
  • Virtuoso A; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, 01100 Viterbo, Italy.
  • Giannarelli D; Biostatistics Unit, Scientific Directorate, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.
  • Giron Berrios JR; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, 01100 Viterbo, Italy.
  • Marrucci E; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, 01100 Viterbo, Italy.
  • Fiore C; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, 01100 Viterbo, Italy.
  • Schirripa M; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, 01100 Viterbo, Italy.
  • Signorelli C; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, 01100 Viterbo, Italy.
  • Chilelli MG; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, 01100 Viterbo, Italy.
  • Primi F; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, 01100 Viterbo, Italy.
  • Pessina G; Department of Oncology and Hematology, Molecular Biology and Covid Diagnostics, Central Hospital of Belcolle, 01100 Viterbo, Italy.
  • Natoni F; Department of Oncology and Hematology, Molecular Biology and Covid Diagnostics, Central Hospital of Belcolle, 01100 Viterbo, Italy.
  • Silvestri MA; Department of Oncology and Hematology, Microbiology and Virology Unit, Central Hospital of Belcolle, 01100 Viterbo, Italy.
  • Ruggeri EM; Department of Oncology and Hematology, Medical Oncology Unit, Central Hospital of Belcolle, 01100 Viterbo, Italy.
Curr Oncol ; 30(5): 5103-5115, 2023 05 17.
Article em En | MEDLINE | ID: mdl-37232844
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 2_enfermedades_transmissibles / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Curr Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 2_enfermedades_transmissibles / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Curr Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália